CVS Group plc
CVSGF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.05 | -1.47 | 0.50 | 1.56 |
| FCF Yield | 8.41% | 3.17% | 2.90% | 3.81% |
| EV / EBITDA | 7.24 | 9.68 | 14.74 | 16.42 |
| Quality | ||||
| ROIC | 7.20% | 5.99% | 11.42% | 7.17% |
| Gross Margin | 38.58% | 42.93% | 43.83% | 43.14% |
| Cash Conversion Ratio | 2.13 | 10.59 | 2.02 | 2.94 |
| Growth | ||||
| Revenue 3-Year CAGR | 16.21% | 5.31% | 4.90% | 9.01% |
| Free Cash Flow Growth | 209.57% | -36.34% | -23.92% | 16.97% |
| Safety | ||||
| Net Debt / EBITDA | 1.44 | 2.50 | 1.73 | 1.55 |
| Interest Coverage | 4.17 | 4.03 | 8.88 | 6.29 |
| Efficiency | ||||
| Inventory Turnover | 19.92 | 11.62 | 11.65 | 12.03 |
| Cash Conversion Cycle | 16.77 | 13.21 | 10.21 | 7.72 |